• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项探索透明细胞肾细胞癌关键路径的研究。

A study exploring critical pathways in clear cell renal cell carcinoma.

作者信息

Zeng Zisan, Que Tengcheng, Zhang Jiange, Hu Yanling

机构信息

Department of Radiology, The First Affiliated Hospital of Guangxi Medical University, Guangxi 530021, P.R. China.

Wild Animal Rescue Center, Forestry Bureau of Guangxi, Guangxi 530021, P.R. China.

出版信息

Exp Ther Med. 2014 Jan;7(1):121-130. doi: 10.3892/etm.2013.1392. Epub 2013 Nov 7.

DOI:10.3892/etm.2013.1392
PMID:24348776
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3861490/
Abstract

Renal cell carcinoma (RCC) is the most lethal type of cancer in the urinary system and often presents as a metastatic disease. Furthermore, there are no effective treatments for the disease. Several studies based on gene expression profiling have been performed with the aim of gaining insights into the pathogenesis of RCC; however, few studies have investigated RCC at the pathway level to search for the possible pathways involved in clear cell RCC (CCRCC). In this study, gene set enrichment analysis (GSEA) was conducted on microarray datasets from CCRCC tissue. DAVID functional enrichment analysis was performed based on the dysregulated genes that were identified in a meta-analysis performed on the microarray datasets from CCRCC tissue. In GSEA, 17 down- and 12 upregulated pathways coexisted in six datasets. The majority of the upregulated pathways were associated with the immune system. In addition, 32 dysregulated pathways were obtained from DAVID functional enrichment analysis, based on the abnormal genes identified by meta-analysis. This study demonstrated that cross-GSEA is a useful method for exploring the critical pathways involved CCRCC; however, an individual dataset with a small sample may introduce bias. A cross-GSEA based on certain well-designed datasets may be required to further the progress made in this study, following the analysis of its results.

摘要

肾细胞癌(RCC)是泌尿系统中最致命的癌症类型,通常表现为转移性疾病。此外,该疾病尚无有效的治疗方法。为了深入了解RCC的发病机制,已经进行了多项基于基因表达谱分析的研究;然而,很少有研究在通路水平上对RCC进行研究,以寻找与透明细胞肾细胞癌(CCRCC)相关的可能通路。在本研究中,对来自CCRCC组织的微阵列数据集进行了基因集富集分析(GSEA)。基于对来自CCRCC组织的微阵列数据集进行的荟萃分析中鉴定出的失调基因,进行了DAVID功能富集分析。在GSEA中,六个数据集中共存17个下调和12个上调的通路。大多数上调的通路与免疫系统相关。此外,基于荟萃分析鉴定出的异常基因,从DAVID功能富集分析中获得了32个失调的通路。本研究表明,交叉GSEA是探索CCRCC相关关键通路的一种有用方法;然而,样本量小的单个数据集可能会引入偏差。在分析其结果之后,可能需要基于某些精心设计的数据集进行交叉GSEA,以推动本研究取得进一步进展。

相似文献

1
A study exploring critical pathways in clear cell renal cell carcinoma.一项探索透明细胞肾细胞癌关键路径的研究。
Exp Ther Med. 2014 Jan;7(1):121-130. doi: 10.3892/etm.2013.1392. Epub 2013 Nov 7.
2
Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.基于基因集富集分析的 clear cell 肾细胞癌基因表达分析用于生物统计学管理。
BJU Int. 2011 Jul;108(2 Pt 2):E29-35. doi: 10.1111/j.1464-410X.2010.09794.x. Epub 2011 Mar 16.
3
Key pathways and genes controlling the development and progression of clear cell renal cell carcinoma (ccRCC) based on gene set enrichment analysis.基于基因集富集分析的控制透明细胞肾细胞癌(ccRCC)发生发展的关键信号通路和基因
Int Urol Nephrol. 2014 Mar;46(3):539-53. doi: 10.1007/s11255-013-0511-2. Epub 2013 Aug 14.
4
Identification and validation of novel prognostic markers in Renal Cell Carcinoma.肾细胞癌中新型预后标志物的鉴定与验证
Dan Med J. 2017 Oct;64(10).
5
The screening of pivotal gene expression signatures and biomarkers in renal carcinoma.肾癌中关键基因表达特征和生物标志物的筛选
J Cancer. 2019 Oct 19;10(25):6384-6394. doi: 10.7150/jca.30656. eCollection 2019.
6
Identification of EGFR as a Novel Key Gene in Clear Cell Renal Cell Carcinoma (ccRCC) through Bioinformatics Analysis and Meta-Analysis.通过生物信息学分析和荟萃分析鉴定 EGFR 为透明细胞肾细胞癌(ccRCC)中的一个新的关键基因。
Biomed Res Int. 2019 Feb 13;2019:6480865. doi: 10.1155/2019/6480865. eCollection 2019.
7
Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.生物信息学分析和验证肾透明细胞癌的基因靶点。
Comput Biol Chem. 2021 Jun;92:107453. doi: 10.1016/j.compbiolchem.2021.107453. Epub 2021 Feb 9.
8
Integrated Analysis of Three Publicly Available Gene Expression Profiles Identified Genes and Pathways Associated with Clear Cell Renal Cell Carcinoma.综合分析三个公开的基因表达谱,确定了与透明细胞肾细胞癌相关的基因和通路。
Med Sci Monit. 2020 Jul 26;26:e919965. doi: 10.12659/MSM.919965.
9
New mechanistic insights of clear cell renal cell carcinoma from integrated miRNA and mRNA expression profiling studies.整合 miRNA 和 mRNA 表达谱研究揭示透明细胞肾细胞癌的新机制见解。
Biomed Pharmacother. 2019 Mar;111:821-834. doi: 10.1016/j.biopha.2018.12.099. Epub 2019 Jan 4.
10
The Identification of Key Gene Expression Signature and Biological Pathways in Metastatic Renal Cell Carcinoma.转移性肾细胞癌关键基因表达特征及生物学通路的鉴定
J Cancer. 2020 Jan 16;11(7):1712-1726. doi: 10.7150/jca.38379. eCollection 2020.

引用本文的文献

1
Causal integration of multi-omics data with prior knowledge to generate mechanistic hypotheses.基于先验知识整合多组学数据以生成机制假设。
Mol Syst Biol. 2021 Jan;17(1):e9730. doi: 10.15252/msb.20209730.
2
A pan-kidney cancer study identifies subtype specific perturbations on pathways with potential drivers in renal cell carcinoma.一项泛肾癌研究确定了肾细胞癌中具有潜在驱动因素的通路的亚型特异性扰动。
BMC Med Genomics. 2020 Dec 28;13(Suppl 11):190. doi: 10.1186/s12920-020-00827-5.
3
Andrographolide sensitizes human renal carcinoma cells to TRAIL‑induced apoptosis through upregulation of death receptor 4.穿心莲内酯通过上调死亡受体 4 增强 TRAIL 诱导的人肾癌细胞凋亡。
Oncol Rep. 2020 Nov;44(5):1939-1948. doi: 10.3892/or.2020.7737. Epub 2020 Aug 18.
4
Transcriptomic analysis by RNA sequencing characterises malignant progression of canine insulinoma from normal tissue to metastatic disease.RNA 测序的转录组分析描绘了犬类胰岛素瘤从正常组织到转移性疾病的恶性进展过程。
Sci Rep. 2020 Jul 14;10(1):11581. doi: 10.1038/s41598-020-68507-z.
5
RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.RBCK1 通过泛素化促进肾细胞癌中的 p53 降解。
Cell Death Dis. 2019 Mar 15;10(4):254. doi: 10.1038/s41419-019-1488-2.
6
Renal Cell Carcinoma: Molecular Aspects.肾细胞癌:分子层面
Indian J Clin Biochem. 2018 Jul;33(3):246-254. doi: 10.1007/s12291-017-0713-y. Epub 2017 Nov 13.
7
Promoter DNA methylation analysis reveals a novel diagnostic CpG-based biomarker and RAB25 hypermethylation in clear cell renel cell carcinoma.启动子 DNA 甲基化分析显示新型透明细胞肾细胞癌诊断性 CpG 标志物和 RAB25 高甲基化。
Sci Rep. 2017 Oct 27;7(1):14200. doi: 10.1038/s41598-017-14314-y.
8
PBRM1 Regulates the Expression of Genes Involved in Metabolism and Cell Adhesion in Renal Clear Cell Carcinoma.PBRM1调节肾透明细胞癌中参与代谢和细胞粘附的基因表达。
PLoS One. 2016 Apr 21;11(4):e0153718. doi: 10.1371/journal.pone.0153718. eCollection 2016.
9
DNA methylation profiling reveals novel diagnostic biomarkers in renal cell carcinoma.DNA甲基化分析揭示了肾细胞癌新的诊断生物标志物。
BMC Med. 2014 Dec 4;12:235. doi: 10.1186/s12916-014-0235-x.
10
Genomic Analysis as the First Step toward Personalized Treatment in Renal Cell Carcinoma.基因组分析是肾细胞癌个体化治疗的第一步。
Front Oncol. 2014 Jul 25;4:194. doi: 10.3389/fonc.2014.00194. eCollection 2014.

本文引用的文献

1
Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.基于基因集富集分析的 clear cell 肾细胞癌基因表达分析用于生物统计学管理。
BJU Int. 2011 Jul;108(2 Pt 2):E29-35. doi: 10.1111/j.1464-410X.2010.09794.x. Epub 2011 Mar 16.
2
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns.通过共识聚类对透明细胞肾细胞癌进行分子分层揭示了不同的亚型和生存模式。
Genes Cancer. 2010 Feb 1;1(2):152-163. doi: 10.1177/1947601909359929.
3
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
4
The genetic basis of kidney cancer: a metabolic disease.肾癌的遗传基础:一种代谢疾病。
Nat Rev Urol. 2010 May;7(5):277-85. doi: 10.1038/nrurol.2010.47.
5
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.UOK 262细胞系,延胡索酸水合酶缺陷(FH-/FH-)型遗传性平滑肌瘤病肾细胞癌:人类癌症中异常能量代谢途径的体外和体内模型
Cancer Genet Cytogenet. 2010 Jan 1;196(1):45-55. doi: 10.1016/j.cancergencyto.2009.08.018.
6
Strong expression of chemokine receptor CXCR4 by renal cell carcinoma cells correlates with metastasis.肾细胞癌细胞中趋化因子受体 CXCR4 的强表达与转移相关。
Clin Exp Metastasis. 2009;26(8):1049-54. doi: 10.1007/s10585-009-9294-3. Epub 2009 Oct 27.
7
Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours.利用Affymetrix基因芯片对集合及单个肿瘤样本进行嫌色性肾细胞癌和肾嗜酸细胞瘤的基因表达谱分析。
Int J Biol Sci. 2009 Jul 29;5(6):517-27. doi: 10.7150/ijbs.5.517.
8
Fumarate hydratase deficiency in renal cancer induces glycolytic addiction and hypoxia-inducible transcription factor 1alpha stabilization by glucose-dependent generation of reactive oxygen species.肾癌中的延胡索酸水合酶缺乏通过葡萄糖依赖性产生活性氧诱导糖酵解成瘾和缺氧诱导转录因子1α稳定。
Mol Cell Biol. 2009 Aug;29(15):4080-90. doi: 10.1128/MCB.00483-09. Epub 2009 May 26.
9
LDH-A inhibition, a therapeutic strategy for treatment of hereditary leiomyomatosis and renal cell cancer.乳酸脱氢酶A(LDH-A)抑制,一种治疗遗传性平滑肌瘤病和肾细胞癌的治疗策略。
Mol Cancer Ther. 2009 Mar;8(3):626-35. doi: 10.1158/1535-7163.MCT-08-1049. Epub 2009 Mar 10.
10
Regulation of endocytosis via the oxygen-sensing pathway.通过氧感应途径对胞吞作用的调节。
Nat Med. 2009 Mar;15(3):319-24. doi: 10.1038/nm.1922. Epub 2009 Mar 1.